Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in Biclotymol (cas 15686-33-6)

Add time:09/02/2019    Source:sciencedirect.com

This study investigates for the first time the thermodynamic changes of Biclotymol upon high-energy milling at various levels of temperature above and below its glass transition temperature (Tg). Investigations have been carried out by temperature modulated differential scanning calorimetry (TM-DSC) and X-ray powder diffraction (XRPD). Results indicate that Biclotymol undergoes a solid-state amorphization upon milling at Tg – 45 °C. It is shown that recrystallization of amorphous milled Biclotymol occurs below the glass transition temperature of Biclotymol (Tg = 20 °C). This displays molecular mobility differences between milled Biclotymol and quenched liquid. A systematic study at several milling temperatures is performed and the implication of Tg in the solid-state transformations generally observed upon milling is discussed. Influence of analysis temperature with respect to interpretation of results was investigated. Finally, it is shown that co-milling Biclotymol with only 20 wt% of amorphous PVP allows a stable amorphous dispersion during at least 5 months of storage.

We also recommend Trading Suppliers and Manufacturers of Biclotymol (cas 15686-33-6). Pls Click Website Link as below: cas 15686-33-6 suppliers

Prev:Collective relaxation dynamics and crystallization kinetics of the amorphous Biclotymol (cas 15686-33-6) antiseptic
Next:Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol (cas 15686-33-6))